Fortune India 500 2025 edition
Rank#400- Total income
- ₹5,934 Cr
- Profit
- ₹568 Cr
Last year #413
Bayer Cropscience Limited - agriculture in Thane, Maharashtra, India. FY 2026 financials & compliance.
Active Listed - NSE: BAYERCROP · BSE: 506285 Public Limited Company agriculture Fortune India 500 · #400 BSE 500
Market Cap
₹15,448 Cr
BAYERCROP · NSE
Share Price
₹3,449.60
+0.36% today
Revenue
₹6,575 Cr
FY 2025-26 · +2.8% YoY
EBITDA
₹874 Cr
Margin 13.3%
Net Profit
₹689 Cr
FY 2025-26 · +21.1% YoY
P/E (TTM)
57.0x
P/B 8.4x
ROE
23.7%
ROCE 28.0%
Debt / Equity
0.03
Interest cover 2.5x
About Bayer Cropscience Limited
Data last updated:
Bayer Cropscience Limited is a public limited company based in Thane, Maharashtra, India, a subsidiary of Bayer Cropscience Ag. It operates in the crop protection segment of the agriculture sector. It was incorporated on 09 September 1958 and has been in existence for over 68 years.
Bayer Cropscience is ranked #400 on the Fortune India 500 (2025). It is part of the BSE 500 index. Its director Pankaj Patel and family are #27 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24210MH1958PLC011173. Its GSTIN is 27AAACB9651K2ZC (Maharashtra). The company holds 31 GST registrations, of which 23 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 506285 and NSE: BAYERCROP.
The company has an authorised share capital of ₹66.3 Cr and a paid-up capital of ₹44.94 Cr. It was formerly known as Bayer Cropscience Private Limited. It is led by directors including Simon Thorsten Wiebusch (Managing Director) and Vinit Rajesh Jindal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Bayer House Central Avenue Hiranandani Estate, Thane, Maharashtra, India – 400607.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹6,574.9 Cr, a growth of 2.8% compared to the previous year. For the same year it recorded a net profit of ₹689.2 Cr (net margin 10.5%) and EBITDA of ₹873.7 Cr (EBITDA margin 13.3%). The net worth stands at ₹2,965.7 Cr (up 4% YoY). Total assets are valued at ₹3,174.9 Cr (up 3.6% YoY).
The company has about 1,187 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹113.57 Cr and satisfied charges of ₹219.4 Cr on record. Court records list 531 cases involving the company, including 318 filed by the company and 213 filed against it; 166 cases are pending. The company has 27 deals on record (19 market trades, 4 acquisitions, 3 secondary share transfers); the latest was in July 2026. Its 7 peer companies in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Coromandel International Limited with revenue of ₹24,444 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 415 overdue payments to 81 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bayer.in.
Company details
CIN L24210MH1958PLC011173
Registration Number 011173
Incorporation Date 09 September 1958
ROC Mumbai
Listing Status Listed - Listed on NSE (BAYERCROP); Listed on BSE (506285)
Company Status Active
Date of Last AGM 21 August 2025
Date of Balance Sheet 31 March 2026
Parent Company Bayer Cropscience Ag
Compliance Status Active Compliant
CIN history
Bayer Cropscience has one previous CIN (Corporate Identification Number): U24210MH1958PLC011173. The current CIN is L24210MH1958PLC011173, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24210MH1958PLC011173 | Current |
| U24210MH1958PLC011173 | Previous |
Key People
Simon Thorsten Wiebusch Managing Director Vinit Rajesh Jindal Whole-Time Director Thomas Hoffmann Director Recognitions & Rankings of Bayer Cropscience
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #27 Pankaj Patel & family ₹91,800 Cr
Stock market indices
BSE 500
Contact details
Bayer Cropscience Limited's registered office is in Thane, Maharashtra. Its website is bayer.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBayer House Central Avenue Hiranandani Estate, Thane, Maharashtra, India – 400607
- IndustryAgriculture, Crop Protection
To see the full contact details of Bayer Cropscience Limited, buy the company report.
Comprehensive company report
Bayer Cropscience Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Bayer Cropscience are manufacturing and agriculture, forestry, fishing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and production of crops and animals. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals |
To see the full business activity and turnover split of Bayer Cropscience Limited, buy the company report.
Financials of Bayer Cropscience Limited
FY 2025-26 filings availableBayer Cropscience Limited reported revenue of ₹6,574.9 Cr (up 2.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹6,575 Cr
+2.8% YoY
EBITDA
₹874 Cr
+26.7% YoY
Profit After Tax
₹689 Cr
+21.1% YoY
Net Worth
₹2,966 Cr
+4.0% YoY
Total Assets
₹3,175 Cr
+3.6% YoY
Total Debt
₹81.80 Cr
-22.2% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 6,575 | 6,394 | 5,106 | 5,140 | 4,734 | 4,261 | 3,609 |
| Revenue growth | +2.8% | +25.2% | -0.7% | +8.6% | +11.1% | +18.1% | - |
| EBITDA | 874 | 690 | 957 | 924 | 811 | 812 | 596 |
| EBITDA margin | +13.3% | +10.8% | +18.7% | +18.0% | +17.1% | +19.1% | +16.5% |
| Profit before tax | 855 | 707 | 941 | 990 | 847 | 794 | 583 |
| Net profit | 689 | 569 | 742 | 678 | 601 | 486 | 571 |
| Net profit margin | +10.5% | +8.9% | +14.5% | +13.2% | +12.7% | +11.4% | +15.8% |
| EPS (₹) | 153.50 | 126.50 | 164.92 | 168.86 | 143.72 | 109.82 | 105.68 |
| Balance sheet | |||||||
| Total assets | 3,175 | 3,066 | 3,022 | 2,938 | 2,728 | 2,681 | 2,698 |
| Net worth | 2,966 | 2,850 | 2,849 | 2,712 | 2,524 | 2,550 | 2,572 |
| Total debt | 81.80 | 105 | 47.10 | 73.50 | 86.40 | 26.30 | 1.50 |
| Cash & bank | 1,422 | 894 | 1,164 | 868 | 787 | 1,210 | 1,071 |
| Net working capital | 2,336 | 2,256 | 2,280 | 2,115 | 1,912 | 1,933 | 1,836 |
| Cash flow | |||||||
| Cash from operations | 1,078 | 262 | 952 | 609 | 216 | 687 | 666 |
| Cash from investing | 72.50 | 85.60 | 0.40 | 83.30 | 64.20 | 6.70 | (28.90) |
| Cash from financing | (624) | (619) | (656) | (613) | (703) | (556) | (148) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,835 | 1,101 | 1,106 | 1,553 | 1,915 | 1,046 | 1,057 | 1,738 |
| Revenue growth (YoY) | -4.2% | +5.2% | +4.6% | -10.6% | +17.4% | - | - | - |
| Other income | 88.90 | 46.60 | 15.90 | 13.80 | 18.70 | 37.10 | 32.20 | 23.70 |
| Total expenses | 1,467 | 898 | 989 | 1,348 | 1,566 | 876 | 1,037 | 1,554 |
| EBITDA | 368 | 203 | 117 | 205 | 348 | 171 | 20.20 | 184 |
| EBITDA margin | +20.0% | +18.4% | +10.6% | +13.2% | +18.2% | +16.3% | +1.9% | +10.6% |
| Depreciation | 50.10 | 37.60 | 14.80 | 14.40 | 27.20 | 34.30 | 15.10 | 14.00 |
| Interest | 4.30 | 5.50 | 5.20 | 4.40 | 4.70 | 5.70 | 3.70 | 3.40 |
| Profit before tax | 402 | 206 | 113 | 200 | 335 | 168 | 33.60 | 190 |
| Tax | 80.50 | 44.30 | 17.30 | 47.60 | 56.50 | 24.60 | (0.60) | 53.80 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 22 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,835 | 1,101 | 1,106 | 1,553 | 1,915 | 1,046 | 1,057 | 1,738 |
| Revenue growth (YoY) | -4.2% | +5.2% | +4.6% | -10.6% | +17.4% | - | - | - |
| Other income | 88.90 | 46.60 | 15.90 | 13.80 | 18.70 | 37.10 | 32.20 | 23.70 |
| Total expenses | 1,467 | 898 | 989 | 1,348 | 1,566 | 876 | 1,037 | 1,554 |
| EBITDA | 368 | 203 | 117 | 205 | 348 | 171 | 20.20 | 184 |
| EBITDA margin | +20.0% | +18.4% | +10.6% | +13.2% | +18.2% | +16.3% | +1.9% | +10.6% |
| Depreciation | 50.10 | 37.60 | 14.80 | 14.40 | 27.20 | 34.30 | 15.10 | 14.00 |
| Interest | 4.30 | 5.50 | 5.20 | 4.40 | 4.70 | 5.70 | 3.70 | 3.40 |
| Profit before tax | 402 | 206 | 113 | 200 | 335 | 168 | 33.60 | 190 |
| Tax | 80.50 | 44.30 | 17.30 | 47.60 | 56.50 | 24.60 | (0.60) | 53.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 6,575 | 6,394 | 5,106 | 5,140 | 4,734 | 4,261 | 3,609 |
| Revenue growth | +2.8% | +25.2% | -0.7% | +8.6% | +11.1% | +18.1% | - |
| Other income | 95.00 | 120 | 78.00 | 168 | 113 | 68.90 | 66.00 |
| Total expenses | 5,701 | 5,704 | 4,149 | 4,216 | 3,923 | 3,450 | 3,013 |
| Employee cost | 438 | 450 | 435 | 534 | 463 | 362 | 362 |
| EBITDA | 874 | 690 | 957 | 924 | 811 | 812 | 596 |
| EBITDA margin | +13.3% | +10.8% | +18.7% | +18.0% | +17.1% | +19.1% | +16.5% |
| Depreciation | 94.00 | 84.90 | 74.00 | 79.50 | 64.50 | 73.50 | 65.30 |
| Interest | 19.80 | 17.00 | 19.60 | 22.30 | 12.90 | 12.60 | 13.80 |
| Profit before tax | 855 | 707 | 941 | 990 | 847 | 794 | 583 |
| Tax | 166 | 139 | 201 | 232 | 202 | 301 | 109 |
| Net profit | 689 | 569 | 742 | 678 | 601 | 486 | 571 |
| Net profit margin | +10.5% | +8.9% | +14.5% | +13.2% | +12.7% | +11.4% | +15.8% |
| EPS (₹) | 153.50 | 126.50 | 164.92 | 168.86 | 143.72 | 109.82 | 105.68 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 44.90 | 44.90 | 44.90 | 44.90 | 44.90 | 44.90 | 44.90 |
| Reserves & surplus | 2,921 | 2,806 | 2,804 | 2,667 | 2,479 | 2,505 | 2,528 |
| Shareholders' funds (net worth) | 2,966 | 2,850 | 2,849 | 2,712 | 2,524 | 2,550 | 2,572 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 81.80 | 105 | 47.10 | 73.50 | 86.40 | 26.30 | 1.50 |
| Total debt | 81.80 | 105 | 47.10 | 73.50 | 86.40 | 26.30 | 1.50 |
| Total liabilities | 3,175 | 3,066 | 3,022 | 2,938 | 2,728 | 2,681 | 2,698 |
| Assets | |||||||
| Gross block | 929 | 875 | 790 | 794 | 743 | 682 | 668 |
| Net block | 458 | 470 | 414 | 462 | 468 | 425 | 468 |
| Capital work in progress | 127 | 119 | 119 | 109 | 98.30 | 76.30 | 55.90 |
| Investments | 57.40 | 35.40 | 53.90 | 41.10 | 38.50 | 52.20 | 40.80 |
| Inventories | 2,136 | 2,362 | 1,545 | 1,807 | 1,512 | 1,325 | 964 |
| Sundry debtors | 1,116 | 952 | 960 | 976 | 1,005 | 755 | 718 |
| Cash & bank balances | 1,422 | 894 | 1,164 | 868 | 787 | 1,210 | 1,071 |
| Loans & advances | 188 | 229 | 182 | 204 | 233 | 202 | 221 |
| Total current assets | 4,861 | 4,436 | 3,852 | 3,855 | 3,537 | 3,492 | 2,974 |
| Total current liabilities | 2,524 | 2,180 | 1,571 | 1,740 | 1,625 | 1,558 | 1,138 |
| Net working capital | 2,336 | 2,256 | 2,280 | 2,115 | 1,912 | 1,933 | 1,836 |
| Total assets | 3,175 | 3,066 | 3,022 | 2,938 | 2,728 | 2,681 | 2,698 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 886 | 1,157 | 861 | 781 | 1,204 | 1,067 | 578 |
| Net cash from operating activities | 1,078 | 262 | 952 | 609 | 216 | 687 | 666 |
| Net cash from investing activities | 72.50 | 85.60 | 0.40 | 83.30 | 64.20 | 6.70 | (28.90) |
| Net cash from financing activities | (624) | (619) | (656) | (613) | (703) | (556) | (148) |
| Net change in cash | 527 | (272) | 296 | 79.40 | (424) | 138 | 489 |
| Closing cash | 1,422 | 894 | 1,164 | 868 | 787 | 1,210 | 1,071 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +2.8% | +25.2% | -0.7% | +8.6% | +11.1% | +18.1% | - |
| EBITDA growth | +26.7% | -27.9% | +3.6% | +13.9% | -0.1% | +36.2% | - |
| PBT growth | +20.9% | -24.9% | -4.9% | +16.9% | +6.6% | +36.3% | +21.5% |
| Net income growth | +21.1% | -23.4% | +9.5% | +12.8% | +23.7% | -14.8% | - |
| Revenue CAGR (3Y) | +8.6% | +10.5% | +6.2% | +12.5% | +14.3% | +16.3% | +8.8% |
| EBITDA CAGR (3Y) | -1.9% | -5.3% | +5.6% | +15.7% | +19.0% | +25.6% | +13.0% |
| Profitability & leverage | |||||||
| Net income margin | +10.5% | +8.9% | +14.5% | +14.8% | +13.6% | +11.6% | +13.2% |
| Return on capital employed | +28.0% | +23.8% | +32.3% | +32.1% | +31.8% | +30.0% | +28.4% |
| Return on net worth | +23.7% | +19.9% | +26.6% | +25.9% | +25.4% | +19.3% | +23.7% |
| Debt / equity | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 |
| Long-term debt / equity | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest cover | 2.54 | 2.81 | 2.22 | 2.64 | 1.73 | 1.71 | 2.60 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 7.29 | 7.68 | 6.45 | 6.69 | 6.64 | 6.31 | 5.78 |
| Inventory turnover | 2.92 | 3.27 | 3.05 | 3.10 | 3.34 | 3.72 | 3.40 |
| Debtors turnover | 6.36 | 6.69 | 5.28 | 5.19 | 5.38 | 5.79 | 5.10 |
| EPS (₹) | 153.50 | 126.50 | 164.92 | 168.86 | 143.72 | 109.82 | 105.68 |
| Dividend per share (₹) | 150.00 | 125.00 | 140.00 | 130.00 | 150.00 | 115.00 | 25.00 |
| Book value per share (₹) | 660.51 | 634.83 | 634.61 | 604.03 | 562.20 | 568.00 | 572.94 |
To see the full year-wise statements and ratios of Bayer Cropscience Limited, buy the company report.
Board of directors of Bayer Cropscience Limited
Bayer Cropscience has 7 current directors and 31 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thomas Hoffmann | Director | 16 Sep 2019 | 7 Years 1 Months | Current |
| Pankaj Ramanbhai Patel Also directs: Zandra Infrastructure LLP, Zydus Hospital LLP, Zandra Herbs and Plantations LLP and 5 more | Director | 05 Jul 2016 | 10 Years 3 Months | Current |
| Simon Thorsten Wiebusch | Managing Director | 01 Nov 2023 | 2 Years 11 Months | Current |
| Sanjiv Rangrass Also directs: Uv Opportunity LLP, Capria Manager Mooru LLP, Zetwerk Manufacturing Businesses Limited and 1 more | Director | 01 Aug 2025 | 1 Years 2 Months | Current |
| Vinit Rajesh Jindal | Whole-Time Director | 01 Mar 2025 | 1 Years 7 Months | Current |
| Jana Marlen Ackermann | Director | 01 Mar 2025 | 1 Years 7 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Bayer Cropscience Limited is compared with the 7 companies closest to it by revenue in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coromandel International Limited | ₹24,444 Cr (FY 2025) | 10.0% | Telangana, India | |||
| Chambal Fertilisers and Chemicals Limited | ₹16,861 Cr (FY 2025) | -7.0% | Kota, Rajasthan, India | |||
| Indorama India Private Limited | ₹10,575 Cr (FY 2025) | 11.0% | Kolkata, West Bengal, India | |||
| Pi Industries Limited | ₹8,322 Cr (FY 2025) | 6.0% | Udaipur, Rajasthan, India | |||
| Bayer Cropscience Limitedthis company | ₹6,574.9 Cr (FY 2026) | ₹689.2 Cr | 10.5% | 2.8% | 1,187 | Thane, Maharashtra, India |
| Gharda Chemicals Limited | ₹3,649.01 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| Southern Petrochemical Industries Corporation Limited | ₹3,100.25 Cr (FY 2025) | 58.0% | Chennai, Tamil Nadu, India | |||
| Sumitomo Chemical India Limited | ₹2,939.62 Cr (FY 2024) | -17.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Bayer Cropscience Limited, buy the company report.
Auditor
Bayer Cropscience Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2022 | 117366W/W-100018 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 71.40%, foreign institutional investors hold 4.00%, domestic institutional investors hold 11.60% and retail and other public shareholders hold 13.00%.
Sep 2026
QUARTER
71.40% Promoters
11.60% DII (Domestic Institutional)
4.00% FII (Foreign Institutional)
13.00% Retail & Others
Promoter holding - history
Now 71.40% · Sep 2026High 71.40% · Dec 2025Low 71.40% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 71.40% | 71.40% | 71.40% | 71.40% |
| Public | 28.60% | 28.60% | 28.60% | 28.60% |
Charges & borrowings
Open charges
₹113.57 Cr
Satisfied charges
₹219.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jan 2000 | 90235976 | Central Bank of India | ₹15 Cr | Open | |
| 20 Aug 1999 | 90231034 | Canaa Bank | ₹60 Lakh | Open | |
| 12 Aug 1999 | 90231032 | Canaa Bank | ₹50 Lakh | Open | |
| 15 Jul 1999 | 90231028 | Canaa Bank | ₹10.5 Cr | Open | |
| 13 Jul 1999 | 90231026 | Canaa Bank | ₹10.5 Cr | Open |
To see the full charge records of Bayer Cropscience Limited, buy the company report.
Total charge records: 51 View all charges
Deals & funding
Bayer Cropscience Limited has 27 deals on record (19 market trades, 4 acquisitions, 3 secondary share transfers); the latest was in July 2026.
Total deals
27
Market trades
19
Acquisitions
4
Secondary share transfers
3
Buyback
1
Deals on record (5 of 27)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2025 | Acquisition | Undisclosed | Buyer: Corona Remedies Limited Seller: Bayer Cropscience Limited |
| Oct 2021 | Acquisition | ₹62 Cr | Buyer: Crystal Crop Protection Limited Seller: Bayer Cropscience Limited |
| Mar 2016 | Market trade | ₹110 Cr | Buyer: Bayer Vapi Private Limited Seller: Bayer Cropscience Ag |
| Apr 2014 | Market trade | ₹406.14 Cr | Buyer: Bayer Vapi Private Limited Seller: Covestro (India) Private Limited , an individual |
| Apr 2014 | Market trade | ₹270.76 Cr | Buyer: Bayer Vapi Private Limited Seller: Covestro (India) Private Limited , an individual |
To see the full deal history of Bayer Cropscience Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bayer Cropscience Limited has 531 court cases on record: 318 filed by Bayer Cropscience, 213 filed against it. 166 cases are pending and 365 are disposed.
Total cases
531
Filed by the company
318
Filed against the company
213
Pending
166
Disposed
365
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 386 | 161 | 139 |
| High courts | 140 | 49 | 27 |
| Supreme Court | 4 | 3 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 531)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed by the company against Harlal Seeds Pvt. Ltd. | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| District court, Latur, Maharashtra | Court case (MACP. M.A.) | Filed against the company | Pending |
| Madras High Court | Civil miscellaneous application | Filed against the company by an individual | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by State Governmentst | Pending |
To see the full case history of Bayer Cropscience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bayer Cropscience Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 415 overdue payments to 81 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 81)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Greif India Plastics Private Limited | |||
| Nahata Datacom Global Corp LLP | |||
| Maharshi Labels Private Limited | |||
| an individual supplier | |||
| Indian Road Freight Carriers |
To see the full MSME payment records of Bayer Cropscience Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bayer Cropscience Limited has a workforce of 1,187 employees on its EPFO records as of Apr 07, 2024, across 3 active EPFO establishments.
Employee count
1,187
Active EPFO establishments
3
Employee growth
-2.86%
GST
Bayer Cropscience has 31 GST registrations: 23 active and 8 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
31
Active
23
Cancelled / inactive
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACB9651K2ZC | Maharashtra | Active | 26 Jul 2017 |
| 03AAACB9651K1ZN | Punjab | Active | 01 Jul 2017 |
| 06AAACB9651K1ZH | Haryana | Active | 01 Jul 2017 |
| 08AAACB9651K1ZD | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bayer Cropscience Limited, buy the company report.
Recent activity
Bayer Cropscience Limited has 63 board changes on record since 2001: 35 appointments and 28 cessations. The latest: Sekhar Natarajan ceased to be Director on 06 Aug 2025.
Filing
Bayer Cropscience Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
AGM
Bayer Cropscience Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Ceased
Sekhar Natarajan ceased to be Director.
Appointed
Sanjiv Rangrass was appointed as Director.
Appointed
Jana Marlen Ackermann was appointed as Director.
Appointed
Vinit Rajesh Jindal was appointed as Whole-Time Director.
Ceased
Dr Miriam Holstein ceased to be Director.
Ceased
Simon Johannes Britsch ceased to be Whole-Time Director.
Ceased
Ketaki Sanat Bhagwati ceased to be Director.
Appointed
Radhika Govind Rajan was appointed as Director.
Ceased
Nikunjkumar Jaysukhlal Savaliya ceased to be Company Secretary.
Ceased
Brian Naber ceased to be Director.
138 earlier events are in the company report.
News
From our blog
Frequently asked questions
Bayer Cropscience is an active public limited company based in Thane, Maharashtra, India. The company works in crop protection, within the agriculture industry. It was incorporated on 09 September 1958 (68+ years old) and is registered under CIN L24210MH1958PLC011173. Listed on BSE: 506285 and NSE: BAYERCROP.
Bayer Cropscience reported revenue of ₹6,574.9 Cr for FY 2025-26 (up 2.8% YoY) based on standalone financials.
Bayer Cropscience has 7 current directors:
- Simon Thorsten Wiebusch - Managing Director
- Vinit Rajesh Jindal - Whole-Time Director
- Thomas Hoffmann - Director
- Pankaj Ramanbhai Patel - Director
- Sanjiv Rangrass - Director
- Jana Marlen Ackermann - Director
- Radhika Govind Rajan - Director
The latest financial statements of Bayer Cropscience on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bayer Cropscience is 27AAACB9651K2ZC, registered in Maharashtra. The company has 31 GST registrations in all, of which 23 are active and 8 are cancelled or inactive. Other active GSTINs include 03AAACB9651K1ZN (Punjab), 06AAACB9651K1ZH (Haryana), 08AAACB9651K1ZD (Rajasthan).
The CIN (Corporate Identification Number) of Bayer Cropscience is L24210MH1958PLC011173. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Bayer Cropscience is a listed company as per MCA records. Its shares are listed on both BSE (code: 506285) and NSE (symbol: BAYERCROP).
Bayer Cropscience has 531 court cases on record: 318 filed by the company and 213 filed against it. 166 are pending. Most are in the district courts.
Bayer Cropscience was incorporated on 09 September 1958, making it 68+ years old. It is registered with the Registrar of Companies, Mumbai.
Bayer Cropscience has 27 deals on record (19 market trades, 4 acquisitions, 3 secondary share transfers); the latest was in July 2026.
The peers of Bayer Cropscience by revenue are Coromandel International Limited, Chambal Fertilisers and Chemicals Limited, Indorama India Private Limited, Pi Industries Limited, Gharda Chemicals Limited and 2 more, all in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sekhar Natarajan ceased to be Director on 06 Aug 2025. Sanjiv Rangrass was appointed as Director on 01 Aug 2025. Jana Marlen Ackermann was appointed as Director on 01 Mar 2025. Bayer Cropscience has 63 board changes on record in total.